Evidence map›Paper›PMID 29652518›Full record

ArticleAmerican journal of respiratory cell and molecular biology2018

Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt.

Shijing Jia, Manisha Agarwal, Jibing Yang, Jeffrey C Horowitz, Eric S White, Kevin K Kim

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Degradation of oxidized phospholipids by lysosomal phospholipase A2 regulates pulmonary fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  5. Review
  6. The fibroinflammatory response in cancer.Nature reviews. Cancer · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. p53 and Myofibroblast Apoptosis in Organ Fibrosis.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shijing Jia1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Manisha Agarwal1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Jibing Yang2 Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Jeffrey C Horowitz1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Eric S White1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Kevin K Kim1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Pulmonary and Critical Care Associates · USUniversity of Michigan · US

Funding

Type I collagen signaling in lung injury and fibrosisR01HL108904 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, KEVIN KEEWOUN · 2012 to 2020
$3.5M
X-Linked Inhibitor of Apoptosis in Fibroblast Phenotypes and Lung FibrosisR01HL141195 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOROWITZ, JEFFREY C · 2018 to 2021
$2.3M
NHLBI NIH HHS R01 HL108904NHLBI NIH HHS R01 HL141195
6 · The paper itself

Abstract

Progressive fibrosis is a complication of many chronic diseases, and collectively, organ fibrosis is the leading cause of death in the United States. Fibrosis is characterized by accumulation of activated fibroblasts and excessive deposition of extracellular matrix proteins, especially type I collagen. Extensive research has supported a role for matrix signaling in propagating fibrosis, but type I collagen itself is often considered an end product of fibrosis rather than an important regulator of continued collagen deposition. Type I collagen can activate several cell surface receptors, including α

Indexed as

3-Phosphoinositide-Dependent Protein KinasesAnimalsCell Line, TumorCollagen Type IIDiscoidin Domain Receptor 2FibroblastsGene Knockdown TechniquesHumansIntegrinsMice, NudeProto-Oncogene Proteins c-aktSignal Transduction3-Phosphoinositide-Dependent Protein KinasesCollagen Type IIDiscoidin Domain Receptor 2IntegrinsPDPK1 protein, humanPdpk1 protein, mouseProto-Oncogene Proteins c-aktapoptosiscollagendiscoidin domain receptor 2fibrosis

Identifiers

PMID29652518
PMCPMC6189640
OpenAlexW2797835639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.